|
1
|
Frazier Life Sciences Management
Palo Alto,
California
|
$79.3M
|
+$94.1M
|
+5,827,415
|
New
|
|
|
2
|
Medicxi Ventures Management
St. Helier,
Jersey
|
$28.1M
|
–
|
–
|
–
|
|
|
3
|
|
$27.9M
|
-$284K
|
-17,597
|
-0.9%
|
|
|
4
|
Janus Henderson Group
London,
|
$27.2M
|
+$2.59M
|
+160,085
|
+9%
|
|
|
5
|
Avidity Partners Management
Dallas,
Texas
|
$26.5M
|
+$808K
|
+50,000
|
+3%
|
|
|
6
|
Vanguard Group
Malvern,
Pennsylvania
|
$26.4M
|
+$240K
|
+14,857
|
+0.8%
|
|
|
7
|
Abingworth
London,
United Kingdom
|
$19.5M
|
+$3.75M
|
+231,971
|
+19%
|
|
|
8
|
|
$18.8M
|
-$1.53M
|
-94,608
|
-6%
|
|
|
9
|
Ensign Peak Advisors
Salt Lake City,
Utah
|
$15M
|
-$3.41M
|
-210,958
|
-16%
|
|
|
10
|
|
$8.99M
|
–
|
–
|
–
|
|
|
11
|
Gilder Gagnon Howe & Co
New York
|
$7.57M
|
+$165K
|
+10,238
|
+2%
|
|
|
12
|
GW&K Investment Management
Boston,
Massachusetts
|
$6.53M
|
+$1.55M
|
+96,090
|
+25%
|
|
|
13
|
StepStone Group
La Jolla,
California
|
$5.75M
|
–
|
–
|
–
|
|
|
14
|
State Street
Boston,
Massachusetts
|
$4.97M
|
+$373K
|
+23,104
|
+7%
|
|
|
15
|
683 Capital Management
New York
|
$4.83M
|
+$1.04M
|
+64,405
|
+22%
|
|
|
16
|
Eventide Asset Management
Boston,
Massachusetts
|
$4.58M
|
–
|
–
|
–
|
|
|
17
|
Geode Capital Management
Boston,
Massachusetts
|
$4.27M
|
+$333K
|
+20,619
|
+7%
|
|
|
18
|
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
$3.2M
|
+$792K
|
+49,000
|
+26%
|
|
|
19
|
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
$2.81M
|
-$611K
|
-37,832
|
-15%
|
|
|
20
|
MPM BioImpact
Boston,
Massachusetts
|
$2.63M
|
+$3.12M
|
+193,326
|
New
|
|
|
21
|
Northern Trust
Chicago,
Illinois
|
$2.43M
|
-$147K
|
-9,095
|
-5%
|
|
|
22
|
|
$2.39M
|
+$48.5K
|
+3,001
|
+2%
|
|
|
23
|
Charles Schwab
San Francisco,
California
|
$1.72M
|
+$46.7K
|
+2,888
|
+2%
|
|
|
24
|
Pura Vida Investments
New York
|
$1.39M
|
+$9.69K
|
+600
|
+0.6%
|
|
|
25
|
Penn Mutual Asset Management
Conshohocken,
Pennsylvania
|
$1.18M
|
+$1.4M
|
+86,940
|
New
|
|
